Review
doi: 10.1016/S1359-6446(05)03624-X.
Predicting protein druggability
Affiliations
- PMID: 16376828
- DOI: 10.1016/S1359-6446(05)03624-X
Item in Clipboard
Review
Predicting protein druggability
Drug Discov Today.
2005 Dec.
Abstract
The ability to predict whether a particular protein can bind with high affinity and specificity to small, drug-like compounds based solely on its 3D structure has been a longstanding goal of structural biologists and computational scientists. The promise is that an accurate prediction of protein druggability can capitalize on the huge investments already made in structural genomics initiatives by identifying highly druggable proteins and using this information in target identification and validation campaigns. Here we discuss the potential utility of tools that characterize protein targets and describe strategies for the optimal integration of protein druggability data with bioinformatic approaches to target selection.
Similar articles
-
Comprehensive identification of "druggable" protein ligand binding sites.Genome Inform. 2004;15(2):31-41. Genome Inform. 2004. PMID: 15706489
-
Form follows function: shape analysis of protein cavities for receptor-based drug design.Proteomics. 2009 Jan;9(2):451-9. doi: 10.1002/pmic.200800092. Proteomics. 2009. PMID: 19142949
-
Computational approaches to identifying and characterizing protein binding sites for ligand design.J Mol Recognit. 2010 Mar-Apr;23(2):209-19. doi: 10.1002/jmr.984. J Mol Recognit. 2010. PMID: 19746440
-
Characterization of protein-ligand interaction sites using experimental and computational methods.Curr Opin Drug Discov Devel. 2006 May;9(3):354-62. Curr Opin Drug Discov Devel. 2006. PMID: 16729732 Review.
-
Structural genomics and drug discovery: all in the family.Curr Opin Chem Biol. 2008 Feb;12(1):32-9. doi: 10.1016/j.cbpa.2008.01.045. Epub 2008 Mar 7. Curr Opin Chem Biol. 2008. PMID: 18282486 Review.
Cited by
-
Estimation of Maximum Recommended Therapeutic Dose Using Predicted Promiscuity and Potency.Clin Transl Sci. 2016 Dec;9(6):311-320. doi: 10.1111/cts.12422. Epub 2016 Oct 13. Clin Transl Sci. 2016. PMID: 27736015 Free PMC article.
-
Targeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions.Cancers (Basel). 2018 Aug 21;10(9):278. doi: 10.3390/cancers10090278. Cancers (Basel). 2018. PMID: 30134553 Free PMC article. Review.
-
Probing the druggability of membrane-bound Rab5 by molecular dynamics simulations.J Enzyme Inhib Med Chem. 2017 Dec;32(1):434-443. doi: 10.1080/14756366.2016.1260564. J Enzyme Inhib Med Chem. 2017. PMID: 28090783 Free PMC article.
-
Acinetobacter baumannii Extracellular OXA-58 Is Primarily and Selectively Released via Outer Membrane Vesicles after Sec-Dependent Periplasmic Translocation.Antimicrob Agents Chemother. 2015 Dec;59(12):7346-54. doi: 10.1128/AAC.01343-15. Epub 2015 Sep 14. Antimicrob Agents Chemother. 2015. PMID: 26369971 Free PMC article.
-
Improving protein-ligand binding site prediction accuracy by classification of inner pocket points using local features.J Cheminform. 2015 Apr 1;7:12. doi: 10.1186/s13321-015-0059-5. eCollection 2015. J Cheminform. 2015. PMID: 25932051 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
